NovaBay Pharmaceuticals, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (39)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Harbin Pharma Invests $300 Million In US-based GNC; Forms China JV
Article By: ChinaBio® Today
Saturday, February 17, 2018 2:58 PM EDT
Harbin Pharma will invest $300 million in GNC Holdings, a US nutritional supplement company, and form a JV for China manufacture and sales.
In this article: GNC, NBY, HCM
Read
Week In Review: 2017 Was Record Investment Year For China Life Science; Final Week Adds $669 Million
Article By: ChinaBio® Today
Saturday, December 30, 2017 4:42 PM EDT
Shanghai's SARI will pay $359 million to acquire a 90% interest in Group NMS, a Milan oncology biopharma. SARI is a biopharma investment firm affiliated with the Chinese Academy of Science research organization with the same name.
In this article: NBY, CBMG, WBA
Read
Week In Review: China's Neusoft Raises $610 Million For Life Science Subsidiaries
Article By: ChinaBio® Today
Sunday, December 21, 2014 4:29 AM EDT
Neusoft, a China software, medical device and internet healthcare company, raised $610 million from investors, which it will spend to increase its healthcare offering
In this article: SCLN, MDCO, LLY, NBY, HCM, CRPNF
Read
The Company You Keep Speaks Volumes: Novabay And Trius
Article By: John Eastman
Thursday, October 3, 2013 4:18 PM EDT
The great potential of a drug or remedy that may make it a significant seller and revenue driver for years to come is one thing. But the partners and interested parties early on suggests a depth that a long term stakeholder should pay attention to.
In this article: NBY, NSRGY, LRLCY, TSRX, BAYRY
Read
All Posts

Latest Tweets for $NBY

No tweets yet!

PARTNER HEADLINES